Alter H J, Seeff L B, Kaplan P M, McAuliffe V J, Wright E C, Gerin J L, Purcell R H, Holland P V, Zimmerman H J
N Engl J Med. 1976 Oct 21;295(17):909-13. doi: 10.1056/NEJM197610212951701.
To determine the relation between the presence of donor DNA polymerase and e antigen, and recipient hepatitis, we tested, under code, serums from a controlled trial of hepatitis B immune globulin used to treat individuals accidentally inoculated with HBs Ag-positive blood. All recipients lacked antibody to HBs Ag. In 29 of 31 donors, both polymerase and e were in perfect agreement; both demonstrated a highly significant correlation with recipient hepatitis (P less than 0.001). DNA polymerase/e-negative blood did not cause hepatitis. Blood containing polymerase or e antigen did not cause hepatitis in six of 31 and four of 18 recipients, respectively. Hepatitis did not correlate with transaminase or duration of antigenemia in the donor. Polymerase and e appear to be indicators of the relative infectivity of HBs Ag-positive serum, particularly after small-volume exposure. They may be important determinants in assessing infectivity of chronic carriers of HBs Ag and in evaluating efficacy of hepatitis B immune globulin and hepatitis B vaccines.
为了确定供体DNA聚合酶和e抗原的存在与受体肝炎之间的关系,我们对一项用于治疗意外接种HBs Ag阳性血液个体的乙肝免疫球蛋白对照试验中的血清进行了编码测试。所有受体均缺乏抗HBs Ag抗体。在31名供体中的29名中,聚合酶和e抗原完全一致;两者均与受体肝炎呈高度显著相关性(P小于0.001)。DNA聚合酶/e抗原阴性的血液不会导致肝炎。分别在31名受体中的6名和18名受体中的4名中,含有聚合酶或e抗原的血液未导致肝炎。肝炎与供体中的转氨酶或抗原血症持续时间无关。聚合酶和e抗原似乎是HBs Ag阳性血清相对传染性的指标,尤其是在小剂量接触后。它们可能是评估HBs Ag慢性携带者传染性以及评估乙肝免疫球蛋白和乙肝疫苗疗效的重要决定因素。